A regulatory effect of IL-21 on T follicular helper-like cell and B cell in rheumatoid arthritis

Arthritis Research and Therapy

Volumn 14, Issue 6, 2012, Pages

  Liu, Rui ^a   Wu, Qian ^a   Su, Dinglei ^a   Che, Nan ^a   Chen, Haifeng ^a   Geng, Linyu ^a   Chen, Jinyun ^a   Chen, Wanjun ^b   Li, Xia ^a,c   Sun, Lingyun ^a  

^a THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^c DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 21; INTERLEUKIN 21 RECEPTOR; NEUTRALIZING ANTIBODY; ANTIRHEUMATIC AGENT; AUTOANTIBODY; CD69 ANTIGEN; CORTICOSTEROID; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN DERIVATIVE; LECTIN; LEUKOCYTE ANTIGEN; T LYMPHOCYTE ANTIGEN;

ADULT; APOPTOSIS; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; BLOOD; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STIMULATION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; FLOW CYTOMETRY; HELPER CELL; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; OVARY FOLLICLE CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RHEUMATOID ARTHRITIS; T FOLLICULAR HELPER CELL; UPREGULATION; ARTHRITIS, RHEUMATOID; CELL CULTURE; DRUG COMBINATION; DRUG EFFECTS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; SEVERITY OF ILLNESS INDEX;

ADRENAL CORTEX HORMONES; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; ANTIRHEUMATIC AGENTS; APOPTOSIS; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; DRUG THERAPY, COMBINATION; FEMALE; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKINS; LECTINS, C-TYPE; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-21; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 84869888919     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4100     Document Type: Article

References (47)

1. Spolski R, Leonard WJ. Interleukin-21: Basic biology and implications for cancer and autoimmunity. Annu Rev Immunol 2008, 26:57-79. 10.1146/annurev.immunol.26.021607.090316, 17953510.
2. Ozaki K, Kikly K, Michalovich D, Young PR, Leonard WJ. Cloning of a type I cytokine receptor most related to the IL-2 receptor beta chain. Proc Natl Acad Sci USA 2000, 97:11439-11444. 10.1073/pnas.200360997, 17218, 11016959.
3. Asao H, Okuyama C, Kumaki S, Ishii N, Tsuchiya S, Foster D, Sugamura K. Cutting edge: The common gamma-chain is an indispensable subunit of the IL-21 receptor complex. J Immunol 2001, 167:1-5.
4. Leonard WJ. Cytokines and immunodeficiency diseases. Nat Rev Immunol 2001, 1:200-208. 10.1038/35105066, 11905829.
5. Strengeil M, Sareneva T, Foster D, Julkunen I, Matikainen S. IL-21 up-regulates the expression of genes associated with innate immunity and Th1 response. J Immunol 2002, 169:3600-3605.
6. Terrier B, Geri G, Chaara W, Allenbach Y, Rosenzwajg M, Costedoat-Chalumeau N, Fouret P, Musset L, Benveniste O, Six A, Klatzmann D, Saadoun D, Cacoub P. Interleukin-21 modulates Th1 and Th17 responses in giant cell arteritis. Arthritis Rheum 2012, 64:2001-2011. 10.1002/art.34327, 22147555.
7. Monteleone G, Pallone F, MacDonald TT. Interleukin-21: a critical regulator of the balance between effector and regulatory T-cell responses. Trends Immunol 2008, 29:290-294. 10.1016/j.it.2008.02.008, 18440864.
8. Spolski R, Leonard WJ. The Yin and Yang of interleukin-21 in allergy, autoimmunity and cancer. Curr Op Immunol 2008, 20:295-301.
9. Linterman MA, Beaton L, Yu D, Ramiscal RR, Srivastava M, Hogan JJ, Verma NK, Smyth MJ, Rigby RJ, Vinuesa CG. IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses. J Exp Med 2010, 207:353-363. 10.1084/jem.20091738, 2822609, 20142429.
10. King C, Tangye SG, Mackay CR. T follicular helper (T(FH)) cells in normal and dysregulated immune responses. Ann Rev Immunol 2008, 26:741-766.
11. Ettinger R, Sims GP, Fairhurst AM, Robbins R, da Silva YS, Spolski R, Leonard WJ, Lipsky PE. IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells. J Immunol 2005, 175:7867-7879.
12. Good KL, Bryant VL, Tangye SG. Kinetics of human B cell behavior and amplification of proliferative responses following stimulation with IL-21. J Immunol 2006, 177:5236-5247.
13. Pene J, Gauchat JF, Lecart S, Drouet E, Guglielmi P, Boulay V, Delwail A, Foster D, Lecron JC, Yssel H. Cutting edge: IL-21 is a switch factor for the production of IgG(1) and IgG(3) by human B cells. J Immunol 2004, 172:5154-5157.
14. Nurieva RI, Chung Y, Hwang D, Yang XO, Kang HS, Ma L, Wang YH, Watowich SS, Jetten AM, Tian Q, Dong C. Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. Immunity 2008, 29:138-149. 10.1016/j.immuni.2008.05.009, 2556461, 18599325.
15. Vogelzang A, McGuire HM, Yu D, Sprent J, Mackay CR, King C. A fundamental role for interleukin-21 in the generation of T follicular helper cells. Immunity 2008, 29:127-137. 10.1016/j.immuni.2008.06.001, 18602282.
16. Bryant VL, Ma CS, Avery DT, Li Y, Good KL, Corcoran LM, Malefyt RD, Tangye SG. Cytokine-mediated regulation of human B cell differentiation into Ig-secreting cells: Predominant role of IL-21 produced by CXCR5(+) T follicular helper cells. J Immunol 2007, 179:8180-8190.
17. Morita R, Schmitt N, Bentebibel SE, Ranganathan R, Bourdery L, Zurawski G, Foucat E, Dullaers M, Oh S, Sabzghabaei N, Lavecchio EM, Punaro M, Pascual V, Banchereau J, Ueno H. Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity 2011, 34:108-121. 10.1016/j.immuni.2010.12.012, 3046815, 21215658.
18. Kashiwakuma D, Suto A, Hiramatsu Y, Ikeda K, Takatori H, Suzuki K, Kagami S, Hirose K, Watanabe N, Iwamoto I, Nakajima H. B and T lymphocyte attenuator suppresses IL-21 production from follicular Th cells and subsequent humoral immune responses. J Immunol 2010, 185:2730-2736. 10.4049/jimmunol.0903839, 20660710.
19. Rankin AL, MacLeod H, Keegan S, Andreyeva T, Lowe L, Bloom L, Collins M, Nickerson-Nutter C, Young D, Guay H. IL-21 Receptor is critical for the development of memory B cell responses. J Immunol 2011, 186:667-674. 10.4049/jimmunol.0903207, 21169545.
20. Zotos D, Coquet JM, Zhang Y, Light A, D'Costa K, Kallies A, Corcoran LM, Godfrey DI, Toellner KM, Smyth MJ, Nutt SL, Tarlinton DM. IL-21 regulates germinal center B cell differentiation and proliferation through a B cell-intrinsic mechanism. J Exp Med 2010, 207:365-378. 10.1084/jem.20091777, 2822601, 20142430.
21. Salaffi F, Carotti M, Ciapetti A, Gasparini S, Filippucci E, Grassi W. Relationship between time-integrated disease activity estimated by DAS28-CRP and radiographic progression of anatomical damage in patients with early rheumatoid arthritis. BMC Musculoskelet Disord 2011, 12:120. 10.1186/1471-2474-12-120, 3123613, 21624120.
22. Vittecoq O, Pouplin S, Krzanowska K, Jouen-Beades F, Menard JF, Gayet A, Daragon A, Tron F, Le Loet X. Rheumatoid factor is the strongest predictor of radiological progression of rheumatoid arthritis in a three-year prospective study in community-recruited patients. Rheumatology 2003, 42:939-946. 10.1093/rheumatology/keg257, 12730503.
23. Miriovsky BJ, Michaud K, Thiele GM, O'Dell JR, Cannon GW, Kerr G, Richards JS, Johnson D, Caplan L, Reimold A, Hooker R, Mikuls TR. Anti-CCP antibody and rheumatoid factor concentrations predict greater disease activity in men with rheumatoid arthritis. Ann Rheum Dis 2010, 69:1292-1297. 10.1136/ard.2009.122739, 3122886, 20439294.
24. Vander Cruyssen B, Hoffman IEA, Peene I, Union A, Mielants H, Meheus L, De Keyser F. Prediction models for rheumatoid arthritis during diagnostic investigation: evaluation of combinations of rheumatoid factor, anti-citrullinated protein/peptide antibodies and the human leucocyte antigen-shared epitope. Ann Rheum Dis 2007, 66:364-369. 10.1136/ard.2006.053470, 1856010, 16840502.
25. Ding B, Padyukov L, Lundstrom E, Seielstad M, Plenge RM, Oksenberg JR, Gregersen PK, Alfredsson L, Klareskog L. Different patterns of associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in the extended major histocompatibility complex region. Arthritis Rheum 2009, 60:30-38. 10.1002/art.24135, 2874319, 19116921.
26. Kuhn KA, Kulik L, Tomooka B, Braschler KJ, Arend WP, Robinson WH, Holers VM. Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. J Clin Invest 2006, 116:961-973. 10.1172/JCI25422, 1421345, 16585962.
27. Petkova SB, Konstantinov KN, Sproule TJ, Lyons BL, Al Awwami M, Roopenian DC. Human antibodies induce arthritis in mice deficient in the low-affinity inhibitory IgG receptor Fc gamma RIIB. J Exp Med 2006, 203:275-280. 10.1084/jem.20051951, 2118221, 16476768.
28. Jungel A, Distler JHW, Kurowska-Stolarska M, Seemayer CA, Seibl R, Forster A, Michel BA, Gay RE, Emmrich F, Gay S, Distler O. Expression of interleukin-21 receptor, but not interleukin-21, in synovial fibroblasts and synovial macrophages of patients with rheumatoid arthritis. Arthritis Rheum 2004, 50:1468-1476. 10.1002/art.20218, 15146416.
29. Jang E, Cho SH, Park H, Paik DJ, Kim JM, Youn J. A positive feedback loop of IL-21 signaling provoked by homeostatic CD4(+)CD25(-) T cell expansion is essential for the development of arthritis in autoimmune K/BxN mice. J Immunol 2009, 182:4649-4656. 10.4049/jimmunol.0804350, 19342640.
30. Prevoo MLL, Vanthof MA, Kuper HH, Vanleeuwen MA, Vandeputte LBA, Vanriel P. Modified disease-activity scores that include 28-joint counts-development and validation in a prospective longitudinal-study of patients with rheumatoid-arthritis. Arthritis Rheum 1995, 38:44-48. 10.1002/art.1780380107, 7818570.
31. Fazilleau N, Mark L, McHeyzer-Williams LJ, McHeyzer-Williams MG. Follicular helper T cells: lineage and location. Immunity 2009, 30:324-335. 10.1016/j.immuni.2009.03.003, 2731675, 19303387.
32. Jin HL, Carrio R, Yu AX, Malek TR. Distinct activation signals determine whether IL-21 induces B cell costimulation, growth arrest, or bim-dependent apoptosis. J Immunol 2004, 173:657-665.
33. Ozaki K, Spolski R, Ettinger R, Kim HP, Wang G, Qi CF, Hwu P, Shaffer DJ, Akilesh S, Roopenian DC, Morse HC, Lipsky PE, Leonard WJ. Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of blimp-1 and bcl-61. J Immunol 2004, 173:5361-5371.
34. Li J, Shen W, Kong K, Liu Z. Interleukin-21 induces T-cell activation and proinflammatory cytokine secretion in rheumatoid arthritis. Scand J Immunol 2006, 64:515-522. 10.1111/j.1365-3083.2006.01795.x, 17032244.
35. Rasmussen TK, Andersen T, Hvid M, Hetland ML, Horslev-Petersen K, Stengaard-Pedersen K, Holm CK, Deleuran B. Increased Interleukin 21 (IL-21) and IL-23 are associated with increased disease activity and with radiographic status in patients with early rheumatoid arthritis. J Rheumatol 2010, 37:2014-2020. 10.3899/jrheum.100259, 20682664.
36. Kuchen S, Robbins R, Sims GP, Sheng C, Phillips TM, Lipsky PE, Ettinger R. Essential role of IL-21 in B cell activation, expansion, and plasma cell generation during CD4(+) T cell-B cell collaboration. J Immunol 2007, 179:5886-5896.
37. Mehta DS, Wurster AL, Whitters MJ, Young DA, Collins M, Grusby MJ. IL-21 induces the apoptosis of resting and activated primary B cells. J Immunol 2003, 170:4111-4118.
38. Avery DT, Deenick EK, Ma CS, Suryani S, Simpson N, Chew GY, Chan TD, Palendira U, Bustamante J, Boisson-Dupuis S, Choo S, Bleasel KE, Peake J, King C, French MA, Engelhard D, Al-Hajjar S, Al-Muhsen S, Magdorf K, Roesler J, Arkwright PD, Hissaria P, Riminton DS, Wong M, Brink R, Fulcher DA, Casanova JL, Cook MC, Tangye SG. B cell-intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans. J Exp Med 2010, 207:155-171. 10.1084/jem.20091706, 2812540, 20048285.
39. Matek TR. The biology of interleukin-2. Ann Rev Immunol 2008, 26:453-479.
40. Kuhn R, Rajewsky K, Muller W. Generation and analysis of interleukin-4 deficient mice. Science 1991, 254:707-710. 10.1126/science.1948049, 1948049.
41. Hirano T, Yasukawa K, Harada H, Taga T, Watanabe Y, Matsuda T, Kashiwamura S, Nakajima K, Koyama K, Iwamatsu A, Tsunasawa S, Sakiyama F, Matsui H, Takahara Y, Taniguchi T, Kishimoto T. Complementary-DNA for a novel human interleukin (BSF-2) that induces lymphocytes-B to produce immunoglobulin. Nature 1986, 324:73-76. 10.1038/324073a0, 3491322.
42. Vonfreedenjeffry U, Vieira P, Lucian LA, McNeil T, Burdach SEG, Murray R. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J Exp Med 1995, 181:1519-1526. 10.1084/jem.181.4.1519, 2191954, 7699333.
43. Akdis CA, Akdis M. Mechanisms and treatment of allergic disease in the big picture of regulatory T cells. J Allergy Clin Immunol 2009, 123:735-746. 10.1016/j.jaci.2009.02.030, 19348912.
44. Young DA, Hegen M, Ma HLM, Whitters MJ, Albert LM, Lowe L, Senices M, Wu PW, Sibley B, Leathurby Y, Brown TP, Nickerson-Nutter C, Keith JC, Collins M. Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis. Arthritis Rheum 2007, 56:1152-1163. 10.1002/art.22452, 17393408.
45. Bubier JA, Sproule TJ, Foreman O, Spolski R, Shaffer DJ, Morse HC, Leonard WJ, Roopenian DC. A critical role for IL-21 receptor signaling in the pathogenesis of systemic lupus erythematosus in BXSB-Yaa mice. Proc Natl Acad Sci USA 2009, 106:1518-1523. 10.1073/pnas.0807309106, 2635818, 19164519.
46. Herber D, Brown TP, Liang S, Young DA, Collins M, Dunussi-Joannopoulos K. IL-21 has a pathogenic role in a lupus-prone mouse model and its blockade with IL-21R.Fc reduces disease progression. J Immunol 2007, 178:3822-3830.
47. Bubier JA, Bennett SM, Sproule TJ, Lyons BL, Olland S, Young DA, Roopenian DC. Treatment of BXSB-Yaa mice with IL-21R-Fc fusion protein minimally attenuates systemic lupus erythematosus. Autoimmunity, Pt B: Novel Applications of Basic Research 2007, 1110:590-601.